Cypress Bioscience Licenses Alexza Pharmaceutical's Staccato(R) Nicotine Novel Nicotine Inhaler Technology for Smoking Cessation Will Expand Cypress's CNS Pipeline; Pulmonary Delivery of Pure Nicotine Aerosols May Address Acute Cravings and Help Smokers Quit
ALXA all the way back from its big gap down & more. News will be coming later this year, but that was an example of what a mishandled order will do do to a small cap biotech stock.